在阿尔茨海默氏病中,微质和星球细胞通过含有陶寡合体的突触消除
Raquel N Taddei1,2, Romain Perbet1, Anastasie Mate de Gerando1
1Neurology Department, Massachusetts General Hospital, Harvard University, Boston, Massachusetts.
JAMA neurology
|October 9, 2023
概括
阿尔茨海默病 (AD) 中的突触损失与陶寡合体和微质细胞和星球细胞过度吞有关,即使没有纠. 这表明早期大脑功能下降的途径.
科学领域:
- 神经科学是一个神经科学.
- 神经病理学神经病理学
背景情况:
- 突触损失是阿尔茨海默病 (AD) 认知衰退的关键相关因子.
- 除了粉样β斑块和神经纤维状结之外的因素可能会导致突触损失和认知缺陷.
- 识别这些因素对于阿尔茨海默病的早期治疗干预至关重要.
研究的目的:
- 调查突触中寡合体积累与微质细胞或星球细胞过度消除突触之间的关联.
- 为了确定这个过程是否与类似AD神经病理负担的个体的认知结果 (痴呆与弹性) 相对相关.
- 在早期AD病理的背景下,探索质细胞在突触损失中的作用.
主要方法:
- 对40个具有不同认知结果和AD神经病理学的人类大脑进行了横截面的死后研究.
- 使用扩展显微镜分析视觉皮层,以评估突触,微质和星球细胞之间的空间关系.
- 粉样β斑块的量化,tau负担,突触密度,突触中的tau寡合体,以及突触的质内化.
主要成果:
- 与弹性大脑和对照人群相比,患有痴呆症的大脑显示有显著的突触元素损失.
- 在患有痴呆症的大脑中,观察到微质细胞和星球细胞增加突触的内化.
- 在患有痴呆症的大脑的突触中更频繁地发现tau寡合体,与质突触消除的增加相关,即使在视觉皮层中没有tau纠.
结论:
- 微质细胞和星体细胞可能会过度消除痴呆症患者的突触.
- 突触中的异常tau寡合体可能标志着质介导突触消除的增加.
- 这一过程可能导致阿尔茨海默氏症患者早期丧失大脑功能.
更多相关视频
06:43A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
12.2K
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
9.3K
相关概念视频
Alzheimer's Disease: Overview
506
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
506
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
